SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TTPH, Tetraphase Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (63)10/5/2017 3:54:37 PM
From: HardToFind  Read Replies (1) | Respond to of 80
 
...suggesting compliance would be difficult with TID dosing. Not sure how that would effect outcomes of a trial.
Well, that's how the first cUTI study failed, before they knew about the "food effect". I guess the next cUTI testing will tell us how well patients will comply.



To: tuck who wrote (63)10/9/2017 1:23:17 AM
From: scaram(o)uche  Respond to of 80
 
Good to know the chatter, thanks.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News